Cleerly ISCHEMIA vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Cleerly ISCHEMIA
by Cleerly
VS
prolaio eVO2peak Module
by Prolaio

AI Verdict

Cleerly ISCHEMIA focuses on analyzing CCTA scans to detect coronary artery ischemia and characterize plaque for personalized heart disease diagnosis and treatment planning. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption from wearable sensor data to assess cardiorespiratory fitness for cardiovascular research and care. While both are FDA-cleared cardiology AI tools, they address distinct clinical questions and utilize different data sources, making them complementary rather than direct competitors.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery anatomy and function to determine the likelihood of vessel-level ischemia. This tool is ideal for physicians seeking to leverage AI-powered CCTA analysis for personalized diagnosis, treatment planning, and comprehensive plaque characterization in patients with suspected heart disease.

View Cleerly ISCHEMIA →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you need to estimate a patient's peak oxygen consumption (eVO2peak) using real-world data from FDA-cleared wearable sensors. This module is well-suited for cardiovascular research, rehabilitation, or ongoing patient monitoring where high-density, longitudinal functional capacity data is valuable as an adjunctive aid in clinical evaluation.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA prolaio eVO2peak Module
Deployment Web-based solution Cloud
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cleerly ISCHEMIA

Cleerly ISCHEMIA offers a comprehensive interactive web-based platform for clinicians, including detailed reports and integration with PowerScribe via API, indicating a streamlined workflow for radiologists. The company also states compliance with usability engineering standards and conducted evaluations with cardiologists.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA provides a direct diagnostic aid for vessel-level ischemia by non-invasively estimating FFR from CCTA scans, validated by multiple clinical trials (CREDENCE and PACIFIC) against invasive FFR as the gold standard. This directly impacts personalized diagnosis and treatment planning for heart disease.

Pricing & Value

Cleerly ISCHEMIA

While both tools have opaque pricing, Cleerly ISCHEMIA has an established Category I CPTu00ae code (75580) for non-invasive estimates of fractional flow reserve, providing a clear pathway for reimbursement and enhancing its financial value proposition for healthcare providers.

Enterprise Readiness

Cleerly ISCHEMIA

Both tools are HIPAA compliant, have BAAs, and FDA clearance. However, Cleerly ISCHEMIA explicitly details its data transfer solution (Cleerly Proxy via VPN or virtual appliance) and integration with PowerScribe via API, demonstrating a more defined strategy for seamless integration into existing hospital IT infrastructure and radiology workflows.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA's ability to non-invasively estimate fractional flow reserve (FFR) from CCTA scans represents a significant innovation, providing functional assessment from anatomical imaging without the need for invasive procedures or separate functional tests. This directly addresses a critical diagnostic challenge in cardiology.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offered specific details regarding readily available support channels (e.g., dedicated support portals, technical contact information) or comprehensive user documentation (e.g., user manuals, extensive FAQs, troubleshooting guides) for either Cleerly ISCHEMIA or prolaio eVO2peak Module.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA prolaio eVO2peak Module
Name Cleerly ISCHEMIA prolaio eVO2peak Module
Company Cleerly Prolaio
Tagline AI-Powered Precision for Non-Invasive Ischemia Detection Heart care, connected.
Primary Function Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level Estimates peak oxygen consumption (eVO2peak) using real-world patient data
Key Inputs CCTA scans Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors
Specialties Cardiology, Radiology Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and prolaio eVO2peak Module.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. In contrast, the prolaio eVO2peak Module is FDA-cleared software that estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care.
Cleerly ISCHEMIA requires Coronary Computed Tomography Angiography (CCTA) scans for its analysis. The prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
Cleerly ISCHEMIA provides AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization, and stenosis severity assessment. The prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) and provides this information as an adjunctive aid in clinical evaluation.
Cleerly ISCHEMIA primarily supports Cardiology and Radiology specialties. The prolaio eVO2peak Module supports Cardiology, Physical Medicine & Rehab, and Sports Medicine.
Cleerly ISCHEMIA focuses on anatomical and functional assessment of coronary arteries by analyzing CCTA scans to detect ischemia and characterize plaque. The prolaio eVO2peak Module, conversely, focuses on estimating functional capacity (peak oxygen consumption) using real-world data collected from wearable sensors.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or prolaio eVO2peak Module

Backers

Who funded each tool's parent company.

Cleerly ISCHEMIA

AI Tool Finder
AI-powered search. Results may not be comprehensive.